Clinical Trial Update: Study of ZIO-101 in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

The update reports the completion of a Phase 1/2 study of ZIO-101 in patients with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ZIO-101

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED